Evidence map›Paper›PMID 38419058›Full record

Trial reportImplementation science : IS2024

Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.

Barrot H Lambdin, Ricky N Bluthenthal, Bryan R Garner, Lynn D Wenger, Erica N Browne, Terry Morris, Lee Ongais, Cariné E Megerian, Alex H Kral

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03924505 (Preventing Opioid Overdose Mortality in the United States), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03924505 nacompletednot on this map

Preventing Opioid Overdose Mortality in the United States

TypeinterventionalSponsorRTI InternationalRan2019 to 2022Enrolled105ConditionsOpioid OverdoseArmsOrganize and Mobilize for Implementation Effectiveness, Dissemination
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Toxidromes.Nature reviews. Disease primers · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Barrot H LambdinRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA. blambdin@rti.org.ORCID 0000-0001-8546-0126
Ricky N BluthenthalKeck Medicine, Department of Population and Public Health Sciences, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.
Bryan R GarnerDepartment of Internal Medicine, College of Medicine, The Ohio State University, 370 W. 9Th Avenue, Columbus, OH, 43210, USA.
Lynn D WengerRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA.
Erica N BrowneRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA.
Terry MorrisRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA.
Lee OngaisSan Francisco AIDS Foundation, 1035 Market Street, 4Th Floor, San Francisco, CA, 94103, USA.
Cariné E MegerianRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA.
Alex H KralRTI International, 2150 Shattuck Avenue, 8Th Floor, Berkeley, CA, 94704, USA.
RTI International · USSan Francisco AIDS Foundation · USThe Ohio State University · USUniversity of Southern California · US

Funding

Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service ProgramsR01DA055277 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI LAMBDIN, BARROT HOPKINS · 2022 to 2025
$2.6M
Preventing Opioid Overdose Mortality in the United StatesR01DA046867 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI LAMBDIN, BARROT HOPKINS · 2018 to 2020
$1.4M
NIDA NIH HHS 1R01DA055277-01NIDA NIH HHS R01 DA046867NIDA NIH HHS R01 DA055277
6 · The paper itself

Abstract

backgroundThe United States (US) continues to face decades-long increases in opioid overdose fatalities. As an opioid overdose reversal medication, naloxone can dramatically reduce opioid overdose mortality rates when distributed to people likely to experience or witness an opioid overdose and packaged with education on its use, known as overdose education and naloxone distribution (OEND). Syringe services programs (SSPs) are ideal venues for OEND with staff who are culturally competent in providing services for people who are at risk of experiencing or observing an opioid overdose. We carried out a randomized controlled trial of SSPs to understand the effectiveness of the organize and mobilize for implementation effectiveness (OMIE) approach at improving OEND implementation effectiveness within SSPs.

methodsUsing simple randomization, 105 SSPs were enrolled into the trial and assigned to one of two study arms - (1) dissemination of OEND best practice recommendations (Control SSPs) or the OMIE approach along with dissemination of the OEND best practice recommendations (i.e., OMIE SSPs). OMIE SSPs could participate in 60-min OMIE sessions once a month for up to 12 months. At 12-month post-baseline, 102 of 105 SSPs (97%) responded to the follow-up survey.

resultsThe median number of sessions completed by OMIE SSPs was 10. Comparing OMIE SSPs to control SSPs, we observed significant increases in the number of participants receiving naloxone (incidence rate ratio: 2.15; 95% CI: 1.42, 3.25; p < 0.01) and the rate of naloxone doses distributed per SSP participant (adjusted incidence rate ratio: 1.97; 95% CI: 1.18, 3.30; p = 0.01). We observed no statistically significant difference in the number of adopted best practices between conditions (difference in means 0.2, 95% CI: - 0.7, 1.0; p = 0.68). We also observed a threshold effect where SSPs receiving a higher OMIE dose had greater effect sizes with regard to the number of people given naloxone and the number of naloxone doses distributed.

conclusionsIn conclusion, the multifaceted OMIE approach was effective at increasing naloxone distribution from SSPs, despite substantial external shocks during the trial. These findings have major implications for addressing the overdose crisis, which has continued unabated for decades.

trial registrationClinicalTrials.gov, NCT03924505 . Registered 19 April 2019.

Indexed as

Drug OverdoseOpiate OverdoseOpioid-Related DisordersHealth EducationHumansNaloxoneNarcotic AntagonistsUnited StatesUnited States Department of Veterans AffairsNaloxoneNarcotic AntagonistsImplementation scienceImplementation strategyOverdose education and naloxone distributionSyringe services programs

Identifiers

PMID38419058
PMCPMC10900734
OpenAlexW4392233841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.